{"id":4906,"date":"2024-04-23T07:47:12","date_gmt":"2024-04-23T12:47:12","guid":{"rendered":"https:\/\/provimarcas.com\/?p=4906"},"modified":"2024-05-02T08:22:39","modified_gmt":"2024-05-02T13:22:39","slug":"colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico","status":"publish","type":"post","link":"https:\/\/provimarcas.com\/en\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/","title":{"rendered":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO"},"content":{"rendered":"<p style=\"font-weight: 400;\">\u201c<em>Desde el a\u00f1o pasado, el Ministerio de Salud ven\u00eda insistiendo en la necesidad de declarar como inter\u00e9s p\u00fablico la patente del medicamento dolutegravir, un f\u00e1rmaco fundamental para el tratamiento de personas diagnosticadas, principalmente, con VIH. El objetivo de dicha declaratoria es que el pa\u00eds pueda fabricar o importar dolutegravir gen\u00e9rico, sin permisos del titular de la patente, ViiV Healthcare, empresa conjunta de GlaxoSmithKline, Pfizer y Shionogi..\u201d<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Informaci\u00f3n tomada de El tiempo.<\/p>\n<p><a href=\"https:\/\/www.eltiempo.com\/salud\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico-3337119\">https:\/\/www.eltiempo.com\/salud\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico-3337119<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>#ELTIEMPO #Ministeriodesalud #VIH<\/p>","protected":false},"excerpt":{"rendered":"<p>\u201cDesde el a\u00f1o pasado, el Ministerio de Salud ven\u00eda insistiendo en la necesidad de declarar como inter\u00e9s p\u00fablico la patente del medicamento [&hellip;]<\/p>","protected":false},"author":3,"featured_media":4907,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/provimarcas.com\/en\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas\" \/>\n<meta property=\"og:description\" content=\"\u201cDesde el a\u00f1o pasado, el Ministerio de Salud ven\u00eda insistiendo en la necesidad de declarar como inter\u00e9s p\u00fablico la patente del medicamento [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/provimarcas.com\/en\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\" \/>\n<meta property=\"og:site_name\" content=\"Provimarcas\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/provimarcas\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-23T12:47:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T13:22:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1671\" \/>\n\t<meta property=\"og:image:height\" content=\"1114\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Paulina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\"},\"author\":{\"name\":\"Paulina\",\"@id\":\"https:\/\/provimarcas.com\/#\/schema\/person\/7d5bd4e128127041f65306151a79d5be\"},\"headline\":\"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO\",\"datePublished\":\"2024-04-23T12:47:12+00:00\",\"dateModified\":\"2024-05-02T13:22:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\"},\"wordCount\":108,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/provimarcas.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png\",\"articleSection\":[\"Espa\u00f1ol\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\",\"url\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\",\"name\":\"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas\",\"isPartOf\":{\"@id\":\"https:\/\/provimarcas.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png\",\"datePublished\":\"2024-04-23T12:47:12+00:00\",\"dateModified\":\"2024-05-02T13:22:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage\",\"url\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png\",\"contentUrl\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png\",\"width\":1671,\"height\":1114},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/provimarcas.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/provimarcas.com\/#website\",\"url\":\"https:\/\/provimarcas.com\/\",\"name\":\"Provimarcas\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/provimarcas.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/provimarcas.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/provimarcas.com\/#organization\",\"name\":\"Provimarcas\",\"url\":\"https:\/\/provimarcas.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/provimarcas.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2022\/09\/ingles_mobile-provimarcas.jpg\",\"contentUrl\":\"https:\/\/provimarcas.com\/wp-content\/uploads\/2022\/09\/ingles_mobile-provimarcas.jpg\",\"width\":480,\"height\":420,\"caption\":\"Provimarcas\"},\"image\":{\"@id\":\"https:\/\/provimarcas.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/provimarcas\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/provimarcas.com\/#\/schema\/person\/7d5bd4e128127041f65306151a79d5be\",\"name\":\"Paulina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/provimarcas.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d736cf8fba37316224357341441b8043?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d736cf8fba37316224357341441b8043?s=96&d=mm&r=g\",\"caption\":\"Paulina\"},\"url\":\"https:\/\/provimarcas.com\/en\/author\/paulina\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/provimarcas.com\/en\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/","og_locale":"en_US","og_type":"article","og_title":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas","og_description":"\u201cDesde el a\u00f1o pasado, el Ministerio de Salud ven\u00eda insistiendo en la necesidad de declarar como inter\u00e9s p\u00fablico la patente del medicamento [&hellip;]","og_url":"https:\/\/provimarcas.com\/en\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/","og_site_name":"Provimarcas","article_publisher":"https:\/\/www.facebook.com\/provimarcas","article_published_time":"2024-04-23T12:47:12+00:00","article_modified_time":"2024-05-02T13:22:39+00:00","og_image":[{"width":1671,"height":1114,"url":"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png","type":"image\/png"}],"author":"Paulina","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paulina","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#article","isPartOf":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/"},"author":{"name":"Paulina","@id":"https:\/\/provimarcas.com\/#\/schema\/person\/7d5bd4e128127041f65306151a79d5be"},"headline":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO","datePublished":"2024-04-23T12:47:12+00:00","dateModified":"2024-05-02T13:22:39+00:00","mainEntityOfPage":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/"},"wordCount":108,"commentCount":0,"publisher":{"@id":"https:\/\/provimarcas.com\/#organization"},"image":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage"},"thumbnailUrl":"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png","articleSection":["Espa\u00f1ol"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/","url":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/","name":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO - Provimarcas","isPartOf":{"@id":"https:\/\/provimarcas.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage"},"image":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage"},"thumbnailUrl":"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png","datePublished":"2024-04-23T12:47:12+00:00","dateModified":"2024-05-02T13:22:39+00:00","breadcrumb":{"@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#primaryimage","url":"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png","contentUrl":"https:\/\/provimarcas.com\/wp-content\/uploads\/2024\/05\/COLOMBIA-ENTREGA-POR-PRIMERA-VEZ-UNA-LICENCIA-OBLIGATORIA-A-UN-MEDICAMENTO-POR-RAZONES-DE-INTERES-PUBLICO.png","width":1671,"height":1114},{"@type":"BreadcrumbList","@id":"https:\/\/provimarcas.com\/colombia-entrega-por-primera-vez-una-licencia-obligatoria-a-un-medicamento-por-razones-de-interes-publico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/provimarcas.com\/"},{"@type":"ListItem","position":2,"name":"COLOMBIA ENTREGA, POR PRIMERA VEZ, UNA LICENCIA OBLIGATORIA A UN MEDICAMENTO POR RAZONES DE INTER\u00c9S P\u00daBLICO"}]},{"@type":"WebSite","@id":"https:\/\/provimarcas.com\/#website","url":"https:\/\/provimarcas.com\/","name":"Provimarcas","description":"","publisher":{"@id":"https:\/\/provimarcas.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/provimarcas.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/provimarcas.com\/#organization","name":"Provimarcas","url":"https:\/\/provimarcas.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/provimarcas.com\/#\/schema\/logo\/image\/","url":"https:\/\/provimarcas.com\/wp-content\/uploads\/2022\/09\/ingles_mobile-provimarcas.jpg","contentUrl":"https:\/\/provimarcas.com\/wp-content\/uploads\/2022\/09\/ingles_mobile-provimarcas.jpg","width":480,"height":420,"caption":"Provimarcas"},"image":{"@id":"https:\/\/provimarcas.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/provimarcas"]},{"@type":"Person","@id":"https:\/\/provimarcas.com\/#\/schema\/person\/7d5bd4e128127041f65306151a79d5be","name":"Paulina","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/provimarcas.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d736cf8fba37316224357341441b8043?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d736cf8fba37316224357341441b8043?s=96&d=mm&r=g","caption":"Paulina"},"url":"https:\/\/provimarcas.com\/en\/author\/paulina\/"}]}},"_links":{"self":[{"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/posts\/4906"}],"collection":[{"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/comments?post=4906"}],"version-history":[{"count":1,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/posts\/4906\/revisions"}],"predecessor-version":[{"id":4908,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/posts\/4906\/revisions\/4908"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/media\/4907"}],"wp:attachment":[{"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/media?parent=4906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/categories?post=4906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/provimarcas.com\/en\/wp-json\/wp\/v2\/tags?post=4906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}